Trials / Completed
CompletedNCT01957904
ArterX Safety and Efficacy Study for Cardiac Indications
Prospective, Multi-Center, Open-Label, Post-Market ArterX® Safety and Efficacy Study Protocol for Cardiac Indications
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Tenaxis Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to confirm the acute safety and performance of the ArterX® Surgical Sealant as a hemostatic agent. The study will collect data in support of publications and future product labeling revisions, to provide additional clinical information on use and further details regarding product safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ArterX Surgical Sealant |
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2013-09-01
- Completion
- 2013-12-01
- First posted
- 2013-10-08
- Last updated
- 2015-11-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01957904. Inclusion in this directory is not an endorsement.